HealthCare Global Enterprises has informed that the directorate General of Health Services, Central Drugs Standard Control Organization (Ethics Committee Division) has issued an order dated June 12, 2026, (received on June 16, 2026) addressed to HCG Central Ethics Committee (located at HCG Towers, Tower-I, P. Kalinga Rao Road, Sampangi Rama nagar, Bangalore, 560027)(HCG KR Unit Ethics Committee), suspending HCG KR Unit Ethics Committee from approving or overseeing any new clinical trial for a period of 24 months.
The above information is a part of company’s filings submitted to BSE.
